New test simplifies genetic testing for breast cancerBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7340.755/a (Published 30 March 2002) Cite this as: BMJ 2002;324:755
- Xavier Bosch
Mortality associated with breast cancer has decreased by 25% over the past decade, Josep Baselga, head of the oncology unit of the Hospital Vall d'Hebrón in Barcelona, told the third European breast cancer conference last week.
In addition to the introduction of new drugs, a leading cause for such reduction was the progressive expansion of screening programmes, he told delegates at the conference in Barcelona, attended by more than 4000 specialists.
The conference also heard from the United Kingdom's Nottingham Research Unit about a new test to detect …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial